| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/01/1999 | WO1999032484A1 Process for the preparation of paroxetine hydrochloride |
| 07/01/1999 | WO1999032483A1 New pharmaceutically active compounds |
| 07/01/1999 | WO1999032482A1 Hypoglycemic imidazoline compounds |
| 07/01/1999 | WO1999032480A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 07/01/1999 | WO1999032478A1 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 07/01/1999 | WO1999032477A1 Ortho-anthranilamide derivatives as anti-coagulants |
| 07/01/1999 | WO1999032476A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032475A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032465A1 Arylthiazolidinedione derivatives |
| 07/01/1999 | WO1999032463A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 07/01/1999 | WO1999032462A1 Triazine compounds for treatment of cns disorders |
| 07/01/1999 | WO1999032461A1 1,4-diazacycloheptane derivatives |
| 07/01/1999 | WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 07/01/1999 | WO1999032457A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 07/01/1999 | WO1999032456A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032455A1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 07/01/1999 | WO1999032454A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors |
| 07/01/1999 | WO1999032453A1 POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032450A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/01/1999 | WO1999032449A2 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032448A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 07/01/1999 | WO1999032441A1 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension |
| 07/01/1999 | WO1999032437A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof |
| 07/01/1999 | WO1999032436A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 07/01/1999 | WO1999032435A1 Naphthalene derivatives |
| 07/01/1999 | WO1999032433A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 07/01/1999 | WO1999032431A1 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL-[2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE |
| 07/01/1999 | WO1999032430A1 Process for the preparation of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine |
| 07/01/1999 | WO1999032175A1 Method and device for in-situ formulation of a medicinal solution for parenteral application |
| 07/01/1999 | WO1999032152A2 Methods for delivering pharmaceutical agents to mucosal surfaces |
| 07/01/1999 | WO1999032151A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | WO1999032150A1 Ace inhibitor-mmp inhibitor combinations |
| 07/01/1999 | WO1999032145A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | WO1999032132A1 A preparation for the treatment of aphtae |
| 07/01/1999 | WO1999032131A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/01/1999 | WO1999032128A1 Orally administrable solid ribavirin dosage forms and process for making them |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 07/01/1999 | WO1999032126A1 Progesterone tablet and preparation method |
| 07/01/1999 | WO1999032125A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 07/01/1999 | WO1999032124A1 Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections |
| 07/01/1999 | WO1999032123A1 The use of brinzolamide to prevent visual field loss |
| 07/01/1999 | WO1999032122A1 Type 2 helper t cell-selective immune response suppressors |
| 07/01/1999 | WO1999032121A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| 07/01/1999 | WO1999032120A1 A method of preventing abuse of opioid dosage forms |
| 07/01/1999 | WO1999032119A1 Opioid agonist/antagonist combinations |
| 07/01/1999 | WO1999032118A1 Molecular dispersion composition with enhanced bioavailability |
| 07/01/1999 | WO1999032117A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors |
| 07/01/1999 | WO1999032115A1 Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof |
| 07/01/1999 | WO1999032114A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 07/01/1999 | WO1999032113A1 Application of enzyme prodrugs as anti-infective agents |
| 07/01/1999 | WO1999032112A1 Method for treating diabetes |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032110A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032108A1 Org-5222 in the treatment of depression |
| 07/01/1999 | WO1999032107A1 Compositions comprising cannabinoids |
| 07/01/1999 | WO1999032106A1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/01/1999 | WO1999032105A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof |
| 07/01/1999 | WO1999032104A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 07/01/1999 | WO1999032103A1 New use of local anaesthetics against vascular headaches |
| 07/01/1999 | WO1999032102A1 Treatment of glc1a glaucoma with glucocorticoid antagonists |
| 07/01/1999 | WO1999032101A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists |
| 07/01/1999 | WO1999032100A2 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative |
| 07/01/1999 | WO1999032099A2 Use of fucane for regulating the reconstruction of connective tissues |
| 07/01/1999 | WO1999032098A2 Combination of a ramba and a tocopherol |
| 07/01/1999 | WO1999032097A2 Phytosterol composition for preventing alzheimer's disease |
| 07/01/1999 | WO1999032096A1 Novel formulations for the transdermal administration of asimadoline |
| 07/01/1999 | WO1999032095A1 Rate controlling membranes for controlled drug delivery devices |
| 07/01/1999 | WO1999032093A1 Oral pharmaceutical pulsed release dosage form |
| 07/01/1999 | WO1999032091A1 Oral pharmaceutical extended release dosage form |
| 07/01/1999 | WO1999032089A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | WO1999032088A1 Aqueous insecticidal pour-on formulation |
| 07/01/1999 | WO1999032087A1 Water-soluble eye drop |
| 07/01/1999 | WO1999032085A2 Novel pharmaceutical compositions of uridine triphosphate |
| 07/01/1999 | WO1999032082A2 Pharmaceutical compositions |
| 07/01/1999 | WO1999032081A1 Transmucosal formulations of levosimendan |
| 07/01/1999 | WO1999032076A1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 07/01/1999 | WO1999032075A1 Compositions for inhibiting gingivitis |
| 07/01/1999 | WO1999032072A1 Compositions and methods for treatment of alopecia |
| 07/01/1999 | WO1999031987A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | WO1999024051A3 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 07/01/1999 | WO1999024025A3 Non-steroidal anti-inflammatories or cox-ii inhibitors for treatment of tumors in the gastro-intestinal tract |
| 07/01/1999 | WO1999020223A3 Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive |
| 07/01/1999 | WO1999019324A3 Antipsychotic substituted piperidine derivatives |
| 07/01/1999 | WO1999016741A3 Lipophilic diesters of chelating agents |
| 07/01/1999 | WO1999015186A8 Cationic polymers as toxin-binding agents |
| 07/01/1999 | WO1999015167A3 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 07/01/1999 | WO1999003817B1 Aliphatic propargylamines as cellular rescue agents |
| 07/01/1999 | DE19757983A1 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) Thermodynamically stable form of (R) -3 [[(4-fluorophenyl) sulfonyl] amino] -1,2,3,4-tetrahydro-9H-carbazol-0-propanoic acid (ramatroban) |
| 07/01/1999 | DE19757414A1 Fettmischung Fatblend |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | DE19757224A1 Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation Method and apparatus for in-situ formulation of a medicinal substance solution for parenteral administration |
| 07/01/1999 | DE19756261A1 Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide New pyridylalkane aryl, alkene and alkincarbonsäureamide |
| 07/01/1999 | DE19756236A1 Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide New piperazinyl substituted pyridylalkane, alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19756235A1 Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide New piperidinylsubstituierte pyridylalkane alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19756212A1 Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide Novel substituted with a cyclic imide pyridylalkane, alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19752843A1 Pantoprazole and omeprazole film tablet and pellet used for treating conditions associated with elevated gastric acid secretion |
| 07/01/1999 | CA2316971A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 07/01/1999 | CA2316321A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |